SCHEMBL84118

SCHEMBL84118

CCCOc1ccc(C(C)(C)c2ccc(OCCC)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.58
PSMB1 P20618 1/20 0.54
PSMB5 P28074 1/20 0.54
PSMB2 P49721 1/20 0.54
LTA4H P09960 1/20 0.52
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
ALDH1A1 P00352 3/20 0.50
TP53 P04637 2/20 0.50
MAPT P10636 2/20 0.50
HPGD P15428 2/20 0.50
TSHR P16473 2/20 0.50
HIF1A Q16665 2/20 0.50
ACACB O00763 2/20 0.50
CYP1A2 P05177 1/20 0.50
PPARG P37231 1/20 0.50
PLK1 P53350 1/20 0.50
KDM4E B2RXH2 3/20 0.49
POLB P06746 1/20 0.49
HTT P42858 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15384650 0.94 NQO1 (0.54) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL22172208 0.92 SMN1; SMN2 (0.51) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL13641412 0.92 SMN1; SMN2 (0.70) SMN1; SMN2LTA4HMEN1KMT2AALDH1A1
SCHEMBL4738149 0.91 SMN1; SMN2 (0.58) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL14962789 0.91 SMN1; SMN2 (0.50) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL11965459 0.91 SMN1; SMN2 (0.60) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL10328457 0.91 LTA4H (0.68) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL12039868 0.91 SMN1; SMN2 (0.50) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL12039594 0.88 SMN1; SMN2 (0.51) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H
SCHEMBL24499242 0.88 HTT (0.51) SMN1; SMN2PSMB1PSMB5PSMB2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1343838-A2 STABILIZER SYSTEM FOR STABILIZING POLYMERS THAT CONTAIN HALOGEN Crompton Vinyl Additives GmbH (DE) 2003-09-17 EP claimed
WO-2002048249-A2 STABILIZER SYSTEM FOR STABILIZING POLYMERS THAT CONTAIN HALOGEN CROMPTON VINYL ADDITIVES GMBH (DE) 2002-06-20 WO claimed
JP-8170006-A None JP disclosed
US-20250349883-A1 MODIFIED SULFIDE SOLID ELECTROLYTE AND PRODUCTION METHOD THEREFOR, AND ELECTRODE COMPOSITE MATERIAL AND LITHIUM ION BATTERY IDEMITSU KOSAN CO.,LTD. (JP) 2025-11-13 US disclosed
US-20250253333-A1 MODIFIED SULFIDE SOLID ELECTROLYTE AND PRODUCTION METHOD FOR SAME, AND ELECTRODE COMBINED MATERIAL AND LITHIUM-ION BATTERY IDEMITSU KOSAN CO.,LTD. (JP) 2025-08-07 US disclosed
CN-119404261-A Modified sulfide solid electrolyte, manufacturing method thereof, electrode composite material and lithium ion battery 出光兴产株式会社 2025-02-07 CN disclosed
CN-119096307-A Modified sulfide solid electrolyte, manufacturing method thereof, electrode composite material and lithium ion battery 出光兴产株式会社 2024-12-06 CN disclosed
WO-2024024825-A1 MODIFIED SULFIDE SOLID ELECTROLYTE AND PRODUCTION METHOD THEREFOR, AND ELECTRODE COMPOSITE MATERIAL AND LITHIUM ION BATTERY 出光興産株式会社 2024-02-01 WO disclosed
US-20230340205-A1 PROCESS FOR PREPARING A HYDROXY GROUP FUNCTIONALIZED THIOETHER BASF SE (DE) 2023-10-26 US disclosed
WO-2023190625-A1 MODIFIED SULFIDE SOLID ELECTROLYTE AND PRODUCTION METHOD FOR SAME, AND ELECTRODE COMBINED MATERIAL AND LITHIUM-ION BATTERY 出光興産株式会社 2023-10-05 WO disclosed
US-20230244147-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-03 US disclosed
EP-1284979-B1 PREPOLYMERIC (METH)ACRYLATES WITH POLYCYCLIC OR AROMATIC SEGMENTS 3M ESPE AG (DE) 2004-12-29 EP disclosed
US-20030166816-A1 Prepolymeric (meth) acrylates with polycyclic or aromatic segments 3M INNOVATIVE PROPERTIES COMPANY 2003-09-04 US disclosed
US-6566413-B1 For dental and dental engineering applications 3M ESPE AG (DE) 2003-05-20 US disclosed
EP-1139973-B1 POLYMERISABLE MATERIALS WHICH ARE BASED ON HARDENABLE SILOXANE COMPOUNDS 3M ESPE AG (DE) 2003-04-23 EP disclosed
EP-1284979-A1 PREPOLYMERIC (METH)ACRYLATES WITH POLYCYCLIC OR AROMATIC SEGMENTS 3M Espe AG (DE) 2003-02-26 EP disclosed
WO-2001092271-A1 PREPOLYMERIC (METH)ACRYLATES WITH POLYCYCLIC OR AROMATIC SEGMENTS 3M ESPE AG (DE) 2001-12-06 WO disclosed
EP-1139973-A2 POLYMERISABLE MATERIALS WHICH ARE BASED ON HARDENABLE SILOXANE COMPOUNDS ESPE Dental AG (DE) 2001-10-10 EP disclosed
WO-2000038619-A2 POLYMERISABLE MATERIALS WHICH ARE BASED ON HARDENABLE SILOXANE COMPOUNDS 3M ESPE AG (DE) 2000-07-06 WO disclosed
JP-H08170006-A FLAME-RESISTANT EPOXY RESIN MOLDING COMPOSITION HOECHST AG 1996-07-02 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230244147-A1 COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND AND POLYMER FOR FORMING ORGANIC FILM OR10J3, PYM1, AP1M1 SMN1; SMN2 3209/4885PSMB1 850/4885PSMB5 2509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.